NeuroPace (NPCE) Competitor Comparison
We are evaluating the key criteria listed to compare NeuroPace (NPCE) against its competitors in the Medical Devices industry.
Market Capitalization
53 / 92Gross Profits
58 / 85Total Revenue
62 / 89EBITDA
61 / 90Free Cashflow
58 / 90Quick Ratio
27 / 90Earnings per Share
55 / 90Dividend yield
0 / 8Total Cash
51 / 90Performance 3 years
32 / 92Performance 5 years
61 / 92Performance 10 years
56 / 92Linearity 3 years
22 / 92Linearity 5 years
61 / 92Linearity 10 years
49 / 92Total Rank
34 / 92Dividend Rank
38 / 92Valuation Rank
16 / 92Piotroski Rank
70 / 92Muliplier Rank
37 / 92Market Capitalization - NPCE ranking 53 / 92
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.